CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- Open-market buys, last 90 days
- $25,980
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$25,980. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2011-06-06 | NIGALAYE ASHOK G Chief Scientific Officer | Conversion · Series E Convertible Preferred Stock | −75 | $1,000.00 | $75K | 2,987.5 |
| 2011-06-06 | EPIC PHARMA LLC 10% owner | Conversion | +2,976,190 | 2,976,190 | ||
| 2011-06-06 | EPIC PHARMA LLC 10% owner | Conversion · Series E Convertible Preferred Stock | −75 | $1,000.00 | $75K | 2,987.5 |
| 2011-06-06 | EPIC INVESTMENTS, LLC 10% owner | Conversion | +2,976,190 | 2,976,190 | ||
| 2011-06-06 | EPIC INVESTMENTS, LLC 10% owner | Conversion · Series E Convertible Preferred Stock | +75 | $1,000.00 | $75K | 2,978.5 |
| 2011-05-25 | Trellus Management Company, LLC 10% owner | Sale | −1,435,000 | $0.13 | $192K | 18,938,485 |
| 2011-05-24 | Trellus Management Company, LLC 10% owner | Sale | −300,000 | $0.16 | $49K | 20,373,485 |
| 2011-03-31 | NIGALAYE ASHOK G Chief Scientific Officer | Purchase · Series E Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 3,062.5 |
| 2011-03-31 | NIGALAYE ASHOK G Chief Scientific Officer | Purchase · Warrants | +40,000,000 | 120,000,000 | ||
| 2011-03-31 | NARINE JEENARINE Director | Purchase · Series E Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 3,062.5 |
| 2011-03-31 | NARINE JEENARINE Director | Purchase · Warrants | +40,000,000 | 120,000,000 | ||
| 2011-03-31 | POTTI RAM Director | Purchase · Series E Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 3,062.5 |
| 2011-03-31 | POTTI RAM Director | Purchase · Warrants | +40,000,000 | 120,000,000 | ||
| 2011-03-31 | EPIC PHARMA LLC 10% owner | Purchase · Series E Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 3,062.5 |
| 2011-03-31 | EPIC PHARMA LLC 10% owner | Purchase · Warrants | +40,000,000 | 120,000,000 | ||
| 2011-03-31 | EPIC INVESTMENTS, LLC 10% owner | Purchase · Series E Convertible Preferred Stock | +1,000 | $1,000.00 | $1.0M | 3,062.5 |
| 2011-03-31 | EPIC INVESTMENTS, LLC 10% owner | Purchase · Warrants | +40,000,000 | 120,000,000 | ||
| 2011-01-18 | DICK CHRIS President & COO | Grant or award · Options | +200,000 | $0.10 | $20K | 200,000 |
| 2011-01-18 | Ward Carter Julian Chief Financial Officer, Sec. | Grant or award · Options | +200,000 | $0.10 | $20K | 200,000 |
| 2009-10-30 | NIGALAYE ASHOK G Chief Scientific Officer | Purchase · Warrants | +40,000,000 | 80,000,000 |
Page 27 of 28 · 542 trades